Alogliptin is a selective dipeptidyl peptidase IV (DPP-4) inhibitor and a member of a new class of oral medications, which includes sitagliptin, vildagliptin, saxagliptin, linagliptin, for the treatment of type 2 diabetes [42]. Here, DPP4 is linked to type 2 diabetes mellitus.